Drugs with Coverage Limitations and New Drug Review
Please Note:
- Date Review Completed and Conclusion columns are blank for those products currently undergoing review. Details will be updated as efficiently as possible following initial review.
- Conclusions are based upon decisions made at the time reviews are completed; historical information is not updated. Product management is subject to change based on new clinical evidence, provider/public feedback, advisory committee recommendations, financial considerations, etc.
- This contains approximately one year of New Drug details.
- Advisory Meeting Month is the month this recommendation will be presented at the quarterly Drug Prior Authorization Committee (DPAC) and Drug Utilization Review (DUR) Board meetings. For meeting dates, please see the MO HealthNet Calendar of Events. Certain agents may also be discussed at the quarterly Rare Disease Advisory Council meeting immediately prior to their presentation at their designated DPAC/DUR meeting.
For more information on this process please view the New Drug Review Process or contact the MO HealthNet Pharmacy Program at MHD.PharmacyAdmin@dss.mo.gov or call 573-751-6963.
| Trade Name | Generic Name | Date Review Began | Date Review Completed | Conclusion | Advisory Committee Month |
|---|---|---|---|---|---|
| SOHONOS 2.5 MG CAPSULE | PALOVAROTENE | 09/05/2023 | January 2024 | ||
| XDEMVY 0.25% DROP | LOTILANER | 09/05/2023 | January 2024 | ||
| SOHONOS 5 MG CAPSULE | PALOVAROTENE | 09/05/2023 | January 2024 | ||
| YCANTH 0.7% SOLUTION | CANTHARIDIN | 09/05/2023 | January 2024 | ||
| SOHONOS 10 MG CAPSULE | PALOVAROTENE | 09/05/2023 | January 2024 | ||
| NITROFURANTOIN 50 MG/5 ML SUSP | NITROFURANTOIN | 09/05/2023 | January 2024 | ||
| AIRSUPRA 90-80 MCG INHALER | ALBUTEROL SULFATE/BUDESONIDE | 08/29/2023 | January 2024 | ||
| VEOPOZ 400 MG/2 ML VIAL | POZELIMAB-BBFG | 08/29/2023 | January 2024 | ||
| EYLEA HD 8 MG/0.07 ML VIAL | AFLIBERCEPT | 08/29/2023 | January 2024 | ||
| AKEEGA 50-500 MG TABLET | TALQUETAMAB-TGVS | 08/22/2023 | January 2024 | ||
| AKEEGA 100-500 MG TABLET | TALQUETAMAB-TGVS | 08/22/2023 | January 2024 | ||
| OPVEE 2.7 MG NASAL SPRAY | NALMEFENE HCL | 08/22/2023 | January 2024 | ||
| IYUZEH 0.005% EYE DROP | LATANOPROST/PF | 08/15/2023 | 09/26/2023 | PDL Product | |
| YUFLYMA(CF) 40 MG/0.4 ML SYRNG | ADALIMUMAB-AATY | 08/15/2023 | 09/26/2023 | PDL Product | January 2024 |
| OLPRUVA 3 GRAM DOSE ENVELOPE | SODIUM PHENYLBUTYRATE | 08/08/2023 | 09/19/2023 | PDL Product | October 2023 |